Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register

REFERENCES

1. 1.↵
   1. Sherrer YS,
   2. Bloch DA,
   3. Mitchell DM,
   4. Roth SH,
   5. Wolfe F,
   6. Fries JF

   . Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. J Rheumatol 1987;14:705–9.

   OpenUrlPubMed
2. 2.↵
   1. Jawaheer D,
   2. Lum RF,
   3. Gregersen PK,
   4. Criswell LA

   . Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 2006;54:3087–94.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Da Silva JA,
   2. Larbre JP,
   3. Spector TD,
   4. Perry LA,
   5. Scott DL,
   6. Willoughby DA

   . Protective effect of androgens against inflammation induced cartilage degradation in male rodents. Ann Rheum Dis 1993;52:285–91.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Ishizuka M,
   2. Hatori M,
   3. Suzuki T,
   4. Miki Y,
   5. Darnel AD,
   6. Tazawa C,
   7. et al.

   Sex steroid receptors in rheumatoid arthritis. ClinSci 2004;106:293–300.

   OpenUrl
5. 5.↵
   1. Kuiper S,
   2. van Gestel AM,
   3. Swinkels HL,
   4. de Boo TM,
   5. Da Silva JA,
   6. van Riel PL

   . Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001;28:1809–16.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Wilder RL

   . Adrenal and gonadal steroid hormone deficiency in the etiopathogenesis of rheumatoid arthritis. J Rheumatol Suppl. 1996 Jul;44:10–2.

   OpenUrlPubMed
7. 7.↵
   1. Sokka T,
   2. Toloza S,
   3. Cutolo M,
   4. Kautiainen H,
   5. Makinen H,
   6. Gogus F,
   7. et al;
   8. QUEST-RA Group

   . Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis ResTher 2009;11:R7.

   OpenUrl
8. 8.↵
   1. Hyrich KL,
   2. Watson KD,
   3. Silman AJ,
   4. Symmons DP;
   5. British Society for Rheumatology Biologics Register

   . Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology 2006;45:1558–65.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Jawaheer D,
   2. Olsen J,
   3. Hetland ML

   . Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis — results from the DANBIO registry. J Rheumatol 2012;39:46–53.

   OpenUrlAbstract/FREE Full Text
10. 10.
    1. Asikainen J,
    2. Nikiphorou E,
    3. Kaarela K,
    4. Lindqvist E,
    5. Hakkinen A,
    6. Kautiainen H,
    7. et al.

    Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up. Clin Exp Rheumatol 2016;34:641–5.

    OpenUrl
11. 11.
    1. Forslind K,
    2. Hafstrom I,
    3. Ahlmen M,
    4. Svensson B;
    5. BARFOT Study Group

    . Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46–52.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Hallert E,
    2. Thyberg I,
    3. Hass U,
    4. Skargren E,
    5. Skogh T

    . Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis 2003;62:667–70.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Bergstra SA,
    2. Machado PM,
    3. van den Berg R,
    4. Landewe RB,
    5. Huizinga TW

    . Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives. Clin Exp Rheumatol 2016;5 Suppl 101:S87–90.

    OpenUrl
14. 14.↵
    1. van der Heijde DM,
    2. van ‘t Hof MA,
    3. van Riel PL,
    4. Theunisse LA,
    5. Lubberts EW,
    6. van Leeuwen MA,
    7. et al.

    Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916–20.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Fries JF,
    2. Spitz P,
    3. Kraines RG,
    4. Holman HR

    . Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Schafer JL

    . Analysis of incomplete multivariate data. Boca Raton: Chapman & Hall/CRC; 1997.
17. 17.↵
    1. Putrik P,
    2. Ramiro S,
    3. Lie E,
    4. Keszei AP,
    5. Kvien TK,
    6. van der Heijde D,
    7. et al.

    Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD. Rheumatology 2016;55:1217–24.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Faarvang KL,
    2. Egsmose C,
    3. Kryger P,
    4. Podenphant J,
    5. Ingeman-Nielsen M,
    6. Hansen TM

    . Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Ann Rheum Dis 1993;52:711–5.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. van der Heijde DM,
    2. van Riel PL,
    3. Nuver-Zwart IH,
    4. van de Putte LB

    . Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up. Lancet 1990;335:539.

    OpenUrlPubMed
20. 20.↵
    1. Gerosa M,
    2. Schioppo T,
    3. Meroni PL

    . Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opin Pharmacother 2016;17:1539–47.

    OpenUrl
21. 21.↵
    1. Couderc M,
    2. Gottenberg JE,
    3. Mariette X,
    4. Pereira B,
    5. Bardin T,
    6. Cantagrel A,
    7. et al;
    8. Club Rhumatismes et Inflammations

    . Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry. Rheumatology 2014;53:1788–93.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Wessels JA,
    2. van der Kooij SM,
    3. le Cessie S,
    4. Kievit W,
    5. Barerra P,
    6. Allaart CF,
    7. et al;
    8. Pharmacogenetics Collaborative Research Group

    . A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum 2007;56:1765–75.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Miller A,
    2. Green M,
    3. Robinson D

    . Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J 1983;286:266.

    OpenUrlFREE Full Text
24. 24.↵
    1. van den Ende CH,
    2. Breedveld FC,
    3. Dijkmans BA,
    4. Hazes JM

    . The limited value of the Health Assessment Questionnaire as an outcome measure in short term exercise trials. J Rheumatol 1997;24:1972–7.

    OpenUrlPubMed